PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · Real-Time Price · USD
42.89
+0.93 (2.22%)
Nov 21, 2024, 4:00 PM EST - Market closed
PTC Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 3,308 | 2,080 | 2,786 | 2,816 | 4,164 | 2,960 | |
Market Cap Growth | 69.02% | -25.35% | -1.06% | -32.38% | 40.68% | 70.95% | |
Enterprise Value | 4,695 | 3,253 | 3,671 | 3,207 | 4,102 | 2,579 | |
Last Close Price | 41.96 | 27.56 | 38.17 | 39.83 | 61.03 | 48.03 | |
PS Ratio | 3.56 | 2.22 | 3.99 | 5.23 | 10.94 | 9.64 | |
PB Ratio | -2.71 | -2.54 | -8.03 | 1958.20 | 8.64 | 4.98 | |
EV/Sales Ratio | 5.21 | 3.47 | 5.25 | 5.95 | 10.77 | 8.40 | |
Debt / Equity Ratio | -2.35 | -2.72 | -4.21 | 882.73 | 2.28 | 0.55 | |
Asset Turnover | 0.58 | 0.52 | 0.38 | 0.26 | 0.20 | 0.22 | |
Inventory Turnover | 16.84 | 27.95 | 36.97 | 33.17 | 23.33 | 15.23 | |
Quick Ratio | 2.00 | 1.72 | 1.39 | 1.74 | 4.23 | 3.15 | |
Current Ratio | 2.10 | 2.02 | 1.71 | 1.87 | 4.44 | 3.30 | |
Return on Equity (ROE) | - | - | - | -216.75% | -81.42% | -53.24% | |
Return on Assets (ROA) | -5.15% | -12.13% | -15.09% | -11.30% | -11.21% | -8.79% | |
Return on Capital (ROIC) | -7.18% | -17.30% | -23.05% | -16.43% | -17.15% | -16.90% | |
Earnings Yield | -13.57% | -30.13% | -20.06% | -18.61% | -10.52% | -8.50% | |
FCF Yield | -5.58% | -8.98% | -13.95% | -9.93% | -5.09% | -3.80% | |
Buyback Yield / Dilution | -3.08% | -4.34% | -1.79% | -6.72% | -12.17% | -26.38% | |
Total Shareholder Return | -3.08% | -4.34% | -1.79% | -6.72% | -12.17% | -26.38% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.